nLIGHT, Inc. — FY2023 Form 10-K
Reporting period: Fiscal year ended December 31, 2023. This filing reports annual results; it does not provide standalone fourth-quarter financial statements. nLIGHT designs and manufactures high-power semiconductor and fiber lasers and related products, serving Industrial, Microfabrication, and Aerospace and Defense markets through its Laser Products and Advanced Development segments.
Financial performance and position
- Revenue: $209.9 million, down 13.3% from $242.1 million in 2022. Product revenue declined 18.7% to $156.7 million; Advanced Development revenue grew 7.8% to $53.3 million.
- End markets: Industrial revenue fell 22.0% to $71.0 million and Microfabrication fell 24.4% to $47.5 million. Aerospace and Defense rose 3.6% to $91.4 million, supported by development contracts despite lower product sales.
- Profitability: Gross profit was $46.1 million, or 22.0% of revenue, versus $50.8 million and 21.0% in 2022. Operating loss was $46.8 million versus $55.1 million; net loss was $41.7 million, or $0.90 per diluted share, versus $54.6 million, or $1.23 per share.
- Margins by segment: Laser Products gross margin improved to 28.7% from 26.0%; Advanced Development margin was 6.8% versus 7.0%. Lower manufacturing costs and variances helped product margin, partly offset by weaker volume and fixed-cost absorption.
- Cash flow: Operating activities provided $10.1 million, compared with $14.5 million used in 2022. The 2023 result included a $41.7 million net loss offset by noncash expenses and working-capital cash generation, including a $14.9 million inventory reduction. Investing used $14.1 million, including $5.3 million of capital expenditures; financing used $0.9 million.
- Liquidity and debt: Management reported $113.1 million of cash, cash equivalents, and marketable securities at year-end. The balance sheet reports $53.2 million cash and $59.7 million marketable securities. No borrowings were outstanding under the $40 million revolving credit facility, which expires in September 2024; the company reported covenant compliance. Management believes existing liquidity is sufficient for working capital and capital expenditures for at least 12 months.
- Other metrics: Inventory decreased to $52.2 million from $67.6 million. Total liabilities were $52.4 million, including lease liabilities. Firm backlog was $108.4 million, up from $80.4 million; an additional $219.3 million of government-contract value was unfunded and is excluded from backlog.
Material changes versus 2022
- Revenue declined mainly because of weaker Industrial and Microfabrication demand and deteriorating market conditions; China revenue fell 44.1% to $11.9 million.
- Operating expenses fell to $92.9 million from $105.9 million, reflecting lower research and development and SG&A costs. Restructuring charges were $0.8 million, compared with $3.9 million in 2022.
- Net loss narrowed by $12.9 million. The improvement also reflected higher net interest income and $2.4 million of realized gains on marketable securities; the company remained loss-making.
- Operating cash flow improved from a $14.5 million use to $10.1 million provided, with inventory reduction an important contributor.
Outlook, commentary, risks, and unusual items
- Outlook: The filing provides no quantified revenue, earnings, or margin guidance. Management expects continued investment in research and development and new products, and identifies customer capital spending, design wins, product volumes, and defense investment as key performance drivers. It cautions that declining selling prices may pressure revenue and margins.
- Concentration and demand risks: The top ten customers represented approximately 66% of 2023 revenue; the U.S. Government represented 18%. Short-term purchase orders, market cyclicality, customer order delays or cancellations, and fixed manufacturing costs create forecasting and utilization risk.
- Trade and supply risks: Export controls and licensing requirements affecting China, potential Chinese trade responses, and reliance on single- or limited-source suppliers could disrupt sales or sourcing. Competition and price pressure may also affect margins.
- Contracts and contingencies: The company is vigorously defending a patent ownership lawsuit filed by Lumentum in 2022; management says a loss is not probable or reasonably estimable and recorded no loss contingency. Government contract funding, audits, and estimates of costs to complete fixed-price contracts are additional risks.
- Restructuring and accounting focus: A fourth-quarter 2023 restructuring reduced headcount in China. Excess and obsolete inventory valuation was the auditor’s critical audit matter; inventory was $52.2 million at year-end. Management reported effective disclosure controls and internal control over financial reporting, and KPMG issued unqualified audit opinions.
Important facts for investors to verify
- Whether Industrial and Microfabrication demand and sales volumes stabilize, and whether the 2023 margin improvement can persist at lower revenue levels.
- Customer concentration, the composition and conversion timing of the $108.4 million funded backlog, and the funding and timing of the $219.3 million unfunded government-contract value.
- Cash generation quality, particularly the contribution from inventory reductions, and whether available liquidity remains adequate as the revolving credit facility approaches its September 2024 expiration.
- Inventory valuation assumptions and future write-down exposure, given product changes, demand uncertainty, and the auditor’s critical audit matter.
- Developments in the Lumentum patent litigation, export-control requirements, and key supplier availability.